Accordingly, one of the three was sealed between two Vietnamese companies - the Company for Vaccine and Biological Production No.1 (VABIOTECH) and the International Progressive Joint Stock Company (AIC) - and Japanese pharmaceutical firm Shionogi. VABIOTECH, a State-owned enterprise under the Ministry of Health, is one of the leading units in the field of research, manufacture and sale of vaccines and biological products for human use in the country.

The transfer and the building of a vaccine factory in Vietnam is scheduled for completion in June 2022.

Their deal targeted the transfer of the Recombinant SARS-CoV-2 Spike Protein, a baculovirus expression vector system, with the parties signing a confidentiality agreement to access vaccine and technology records.

Regarding the technology transfer project between the AIC and Shionogi, the Ministry of Health has signed a cooperation agreement. The ministry is preparing a plan to conduct the third phase of clinical trials in Vietnam (via the National Institute of Hygiene and Epidemiology) and procedures for technology transfer (via VABIOTECH). It is expected that the vaccine will be completed and on the market in June 2022.

The second contract involving Russian Sputnik V vaccine was inked between VABIOTECH, DS-Bio, and the Russian Direct Investment Fund, with the Vietnamese side being in charge of packaging the vaccine tubes from the semi-finished products.

VABIOTECH has sent its sample tubes to Russia for quality check. After related tests finished on August 10 as scheduled, Sputnik-V vaccine tubes would be produced under the contract at a volume of 5 million doses per month. It would start with 500,000 doses in August and later scale up to 100 million doses per year.

For technology transfer projects with US partners, the Ministry of Health has sent a group of experts to coordinate with the World Health Organisation (WHO) to support relevant units in completing dossiers for clinical trials phase 1-2-3 according to a shortened process, with the research expected to start on August 1 and end in late December.

The transfer and the building of a vaccine factory in Vietnam will be completed in June 2022.

First batch of Sputnik V vaccine produced in Vietnam

VABIOTECH, one of Vietnam’s leading pharmaceutical companies, and the Russian Direct Investment Fund (RDIF) on July 21 announced the production of a test batch of the Russian Sputnik V vaccine against the coronavirus in Vietnam.

Over 1,000 second shots of Nano Covax vaccine administered to volunteers in third-phase trials

More than 1,000 volunteers received their second shots of homegrown Nano Covax vaccine in its third phase of human trials, as announced by the Defence Ministry’s Military Medical University on July 19.

Vietnam aims to have domestic Covid-19 vaccine produced by 2021

Deputy Health Minister Tran Van Thuan has stressed that Vietnam aims to have a domestic Covid-19 vaccine produced by 2021.

US to give Vietnam another 3 million Moderna vaccine doses

The U.S. will provide Vietnam an additional three million doses of the Moderna Covid-19 vaccine via the Global Alliance for Vaccines and Immunization, the U.S. Embassy in Hanoi said Friday.

Khanh Hoa prepares plans to trial vaccine passport

Khanh Hoa, home to tourist hotspot Nha Trang, plans to trial a program to welcome vaccinated foreign tourists later this year with several restrictions.

Source: NDO/VNA